Vylor, Inc. announced its Q3 2026 financial results showing a slight decline in net sales and increased losses compared to last year, mainly due to volume decreases from weather and market shifts. Despite this, the company saw strong demand for its hybrid seeds and licensing income, particularly in the Americas, and maintained its full-year 2026 guidance with expected adjusted operating EBITDA around $2.8 billion. Vylor also launched a $3 billion share repurchase program and declared a $0.13 per share dividend, signaling confidence in its long-term growth and value creation strategy. The company highlighted a robust technology pipeline and reiterated targets for 2029, aiming for sustained growth and profitability.
Vylor's Q3 2026 results and strategic moves provide context for market activity. For readers following US stocks on Pluang, here is the market snapshot as of Nov 12, 2026 04:11 WIB: out of 150 priced stocks, 92 rose and 58 fell. Notable movers include MRVL at USD 170.01 with a 10.12% increase, IQ at USD 0.96 rising 8.82%, and ZM at USD 98.00 up 7.80%.
The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...
DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...
Castle Biosciences, a diagnostics company specializing in tests for dermatologic and gastroenterological diseases, announced its executive management will present a company overview at the Piper Sandler 38th Annual Healthcare Conference on December 2...
Octave Intelligence plc has acquired Cerebre, a U.S.-based software firm that creates connected plant models by integrating engineering schematics and plant data. This acquisition aims to strengthen Octave's industrial AI capabilities, especially for...
Cardinal Health's Board of Directors has approved a quarterly dividend of $0.5158 per share, to be paid on January 15, 2027. This dividend will be distributed from the company's capital surplus to shareholders recorded by January 4, 2027. Cardinal He...
